Full Text
MSR149 Modeling Price Premiums of Oncology Drugs in Germany: A Cross-Validated Analysis Using XGBoost

Abstract

Authors

Federico Felizzi Volkan Beykoz

Back to Volume 28, Supplemental Issue 12S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×